AI assistant
Sending…
Jazz Pharmaceuticals plc — Director's Dealing 2020
Dec 4, 2020
30751_dirs_2020-12-03_79eb7d13-d396-4012-b832-bc849af2cd2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-12-01
Reporting Person: Smith Mark Douglas (Director)
More from Jazz Pharmaceuticals plc
Regulatory Filings
2026
May 29
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2